Literature DB >> 24988928

ASPECCT: panitumumab versus cetuximab for colorectal cancer--authors' reply.

Timothy J Price1, Marc Peeters2, Paul Ruff3, Swaminathan Murugappan4, Roger Sidhu4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24988928     DOI： 10.1016/S1470-2045(14)70291-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

1.  High incidence of cetuximab-related infusion reactions in head and neck patients.

Authors:  Virginia Palomar Coloma; Pamela Bravo; Naima Lezghed; Lamia Mayache-Badis; Ruth Gabriela Herrera Gómez; Mariana Iacob; Laurence Nicouleau; Romain Desmaris; Yungan Tao; Cristian Leibu; Margarida Matias; Francois Lemare; Caroline Even; Maxime Annereau; Charles Ferté
Journal:  ESMO Open       Date:  2018-07-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.